Intraperitoneal nivolumab in a patient with pancreatic cancer and refractory malignant ascites

Eur J Cancer. 2021 May:148:48-50. doi: 10.1016/j.ejca.2021.01.045. Epub 2021 Mar 15.

¹ Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung, 40402, Taiwan.
² Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung, 40402, Taiwan; Cancer Center, China Medical University Hospital, Taichung, 40402, Taiwan; College of Medicine, School of Medicine, China Medical University, Taichung, 40402, Taiwan.
³ Bachelor of Science and Art in Nutrition, Molecular Biosciences, The University of Texas at Austin, TX 78712, USA.
⁴ Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung, 40402, Taiwan; College of Medicine, School of Medicine, China Medical University, Taichung, 40402, Taiwan. Electronic address: lybai6@gmail.com.

No abstract available

Publication types